0001420506-24-000568.txt : 20240520 0001420506-24-000568.hdr.sgml : 20240520 20240401163128 ACCESSION NUMBER: 0001420506-24-000568 CONFORMED SUBMISSION TYPE: SCHEDULE 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240401 DATE AS OF CHANGE: 20240401 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NeuroMetrix, Inc. CENTRAL INDEX KEY: 0001289850 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 043308180 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-80350 FILM NUMBER: 24809909 BUSINESS ADDRESS: STREET 1: 1000 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781) 890-9989 MAIL ADDRESS: STREET 1: 1000 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: RS Fund LP CENTRAL INDEX KEY: 0001900526 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13D/A BUSINESS ADDRESS: STREET 1: 108 WEST 13TH STREET CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 2159390313 MAIL ADDRESS: STREET 1: 108 WEST 13TH STREET CITY: WILMINGTON STATE: DE ZIP: 19801 SCHEDULE 13D/A 1 primary_doc.xml SCHEDULE 13D/A 0001171520-24-000139 0001900526 XXXXXXXX LIVE 2 Common Stock, $0.0001 par value per share 02/23/2024 true 0001289850 641255880 NeuroMetrix, Inc. (NURO)

4b Gill Street Woburn MA 01801

Ryan Siegal 215-939-0313 420 E 51st Street Unit 8d New York NY 10022 0001900526 N Ryan Siegal PF N X1 150000 0 150000 0 150000 N 9.9 IN Ryan Siegal is the Executive Officer of RS Fund, LP Common Stock, $0.0001 par value per share NeuroMetrix, Inc. (NURO) 4b Gill Street Woburn MA 01801 Ryan Siegal, a citizen of the United States and resident of New York 420 E 51 st Street, Unit 8d, New York, New York 10022 Ryan Siegal, Executive Officer of RS Fund LP No No Ryan Siegal is a citizen of the United States. Personal Funds were used to make the purchase in a portfolio account, but it is not a loan from a bank. The securities were purchased through an open market acquisition. NeuroMetrix, Inc. publicized a strategic review which led to the purchase by RS Fund LP and there may be an intention to influence. There is a potential for an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the issuer or any of its subsidiaries. There is also a potential for any material change in the present capitalization or dividend policy of the issuer. Additionally, the purpose of the transactions were pursuant to an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the issuer or any of its subsidiaries; and, any material change in the present capitalization or dividend policy of the issuer. The following purposes of transactions do not apply: (a) The acquisition by any person of additional securities of the issuer, or the disposition of securities of the issuer; (c) An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the issuer or any of its subsidiaries; (d) A sale or transfer of a material amount of assets of the issuer or any of its subsidiaries; (e) Any change in the present board of directors or management of the issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (f) Any other material change in the issuer's business or corporate structure including but not limited to, if the issuer is a registered closed-end investment company, any plans or proposals to make any changes in its investment policy for which a vote is required by section 13 of the Investment Company Act of 1940; (g) Changes in the issuer's charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the issuer by any person; (h)Causing a class of securities of the issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (i) A class of equity securities of the issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Act; or (j) Any action similar to any of those enumerated above. Amount Beneficially Owned: 150,000, 9.9% of the class of securities, beneficially owned by Ryan Siegal. Ryan Siegal Sole Power to vote or to direct the vote: 150,000; Ryan Siegal Sole Power to dispose or to direct the disposition of: 150,000; Ryan Siegal Percent of Class: 9.9% Ryan Siegal made the sale on March 4, 2024; the amount of securities involved were 4,636 shares of Common Stock, for an average price per share of $4.2574, with the transaction occurring through an open market acquisition. Not applicable Not applicable Not applicable Ryan Siegal Ryan Siegal 04/01/2024